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PublishedSCRS an
by ElsevPURPOSE: To evaluate the biocompatibility of the Flexivue Microlens intracorneal inlay based on
healing of corneal wounds and analysis of corneal structural features using in vivo confocal micro-
scopy (IVCM) and anterior segment optical coherence tomography (AS-OCT).
SETTING: Ophthalmology Department, Misericordia e Dolce Hospital, Prato, Italy.
DESIGN: Case series.
METHODS: The intracorneal inlay was inserted in a stromal pocket created in the nondominant eye
of emmetropic presbyopic patients using a femtosecond laser. In vivo confocal microscopy and
AS-OCT examinations were performed preoperatively and 1, 6, and 12 months postoperatively.
RESULTS: The mean follow-up was 7.6 months. In the early postoperative period, IVCM showed
intense cellular activity in the stroma around the inlay, edema, inflammation, and degenerative
material deposition but normal regularity after 12 months. Anterior segment OCT showed a
regular planar shape of the corneal pocket in all eyes. The mean of the side-cut angles was 30.7
degrees. The mean difference between the measured and planned pocket depth was 9.77 mm. At
1 month, hyperreflective areas beneath the inlay and microfolds were observed in 21 of the 52
eyes. After 12 months, the anterior segment profile was regular and interface pocket reflectivity
decreased over time. Six patients had inlay removal postoperatively (3 before 6 months; 3 before
12 months); after removal, IVCM and AS-OCT showed clear corneas without signs of irregularity.
CONCLUSION: In vivo confocal microscopy and AS-OCT analysis showed that the inlay elicited a
low-level wound-healing response in its immediate vicinity with no alteration in the corneal
structures.
Financial Disclosure: Dr. M. Fantozzi is a member of the Presbia medical advisory board. No other
author has a financial or proprietary interest in any material or method mentioned.
J Cataract Refract Surg 2014; 40:545–557 Q 2014 ASCRS and ESCRSWithanever-growingpopulationof patients older than
45 years, the number of reported cases of age-related
conditions, such as presbyopia, continues to increase
annually. Corneal procedures for the treatment of pres-
byopia include presbyopic laser in situ keratomileusis
(LASIK), conductive keratoplasty, intracorneal im-
plants (or inlays),1–3 and Intracor4 and Supracor laser
procedures (Technolas, Bausch & LombA).
Recent advances in femtosecond laser and material
technologies and a growing demand by informed pa-
tients for a removable treatment option for presbyopiad ESCRS
ier Inc.are contributing factors to a renewed interest in intra-
corneal inlay options. The FlexivueMicrolens intracor-
neal inlay (Presbia Co€operatief U.A.) was designed to
improve the near focus in the nondominant eye
through the bifocal-optic lenticule design.B
To examine the biocompatibility of the intracorneal
inlay, we used 2 anterior segment diagnostic tools to
identify changes after inlay insertion in the cornea:
in vivo confocal microscopy (IVCM) and anterior
segment optical coherence tomography (AS-OCT).
Both diagnostic tools are useful for ocular surface0886-3350/$ - see front matter 545
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tant noninvasive instrument that can be used to detect
histologic changes by providing morphologic and
quantitative data associated with the corneal layers.9
Anterior segment OCT is another tool for the evalua-
tion of corneal and anterior chamber structures; it is
useful because it shows corneal thickness, flap or
pocket morphology and thickness, and the progres-
sive healing of the cornea.10 To date, we are aware of
only 1 published study that used these 2 tools to eval-
uate the postoperative outcomes in eyes that had inser-
tion of the Flexivue Microlens.11
In this study of patients treated with the Flexivue
Microlens intracorneal inlay, we present the results
of the use of IVCM to evaluate biocompatibility and
corneal wound healing and AS-OCT to measure
corneal and pocket thickness.PATIENTS AND METHODS
This morphologic case series study was designed as a 1-year
prospective nonrandomized noncomparative study to eval-
uate the biocompatibility of the Flexivue Microlens intracor-
neal inlay in emmetropic presbyopic patients. Surgeries were
performed at the Ophthalmology Department, Misericordia
e Dolce Hospital, Prato, Italy. The study was performed in
accordance with the Declaration of Helsinki and approved
by the hospital's ethics committee. All patients provided
signed informed consent for participation in the study after
receiving a detailed explanation of the purpose, procedure,
and patient responsibilities.
Patients were eligible for inclusion in the study if they
were naturally emmetropic and presbyopic, between 45
years and 65 years of age, and had a preoperative refractive
spherical equivalent (SE) power between1.0 D andC1.0 D
with no more than C1.0 D of refractive cylinder. Patients
were required to have a preoperative uncorrected near visual
acuity of 20/50 or worse in the surgical eye and uncorrected
distance visual acuity (UDVA) of 20/32 or better in both eyes
with no amblyopia. Additional key inclusion criteria
included a minimum central corneal thickness (CCT) of
500 mm and an endothelial cell density (ECD) of 2000
cells/mm2 in the surgical eye. All patients were required toSubmitted: December 19, 2012.
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J CATARACT REFRACT SURGhave a stable refraction (manifest refraction withinG0.50 D
sphere) 12 months before surgery.
Key exclusion criteria were previous ocular surgery, ante-
rior or posterior segment disease or degeneration, and a
disorder or systemic medication (eg, use of steroids, medica-
tions for diabetes) that could increase operative risks and
interfere with the ordinary healing process. In addition,
patients with distorted nonreactive or decentered pupils, a
photopic pupil diameter smaller than 3.0 mm, severe dry
eye (Schirmer test!3.0mm), or severe corneal abnormalities
(eg, endothelial dystrophy, guttata in the central cornea) in
the eye to be treated were excluded from the study.Intracorneal InlayThe Flexivue Microlens is a transparent hydrophilic disk
with a 3.0 mm diameter and an edge thickness of approxi-
mately 15 mm. The central 1.6 mm diameter of the disk is
plano, while the peripheral zone provides near addition
power. The base powers available range from C1.50 diop-
ters (D) to C3.50 D in 0.25 D increments. At the center of
the disk is a 0.51 mm hole for the transfer of oxygen and
nutrients to the cornea.Surgical TechniqueAll surgeries were performed by the same experienced
surgeon (M.F.) between January 2010 and July 2012. One
day before surgery, patients were instructed to start topical
levofloxacin (Oftaquix) treatment in combination with
topical tobramycin–dexamethasone (Tobradex) drops 4
times daily. Ten minutes before surgery, topical flurbiprofen
(Ocufen) and topical lidocaine 4.0%were administered in the
operated eye; these medications could be repeated as needed
during the procedure. The lids and ocular adnexa of patients
were cleaned with povidone–iodine. A sterile drape was
used to isolate the lid margin. A lid speculum was used to
provide maximum corneal exposure, and the fornices were
irrigated with a balanced salt solution.
The corneas of the patients were marked with a 3.0 mm
ring epithelial marker (Thornton Optic Zone Marker, Amer-
ican Surgical Instruments Corp.) using the first Purkinje
reflex corresponding to applicable visual axes without
damaging the epithelium. Centration was established using
an excimer laser; that is, patients fixated on the microscope
light, and the center of the visual axes of patients was
marked to obtain optimum centration for insertion of the in-
tracorneal inlay. The pocket was created using standard
femtosecond laser parameters (Table 1) associated with
traditional LASIK in conjunction with a mask that was
used to create a pocket to facilitate inlay implantation
without affecting the rest of the cornea. After corneal pocket
creation, patients were situated under the operating micro-
scope for intracorneal inlay insertion. The pocket was sepa-
rated using a manipulator (oval spatula part #6-870,
Duckworth & Kent Ltd. or Storz Ophthalmics; part
#SP7-62541, Bausch & Lomb) until it reached approximately
1.6 to 2.0 mm nasal to the marked center of the cornea.
After pocket preparation was complete, the intracorneal
inlaywas removed from the sterile packagingwith a forceps,
inspected for integrity under highmagnification, and loaded
in the inserter (Flexivue Microlens Inserter, Presbia
Co€operatief U.A.). The inserter holds the lens between 2
leaves, keeping the lens protected and in place for insertion
in the corneal pocket. When ready to insert the inlay, the- VOL 40, APRIL 2014
Table 1. Laser parameters for femtosecond laser–assisted




Hinge Opposite of tunnel
Diameter (mm) 9.0 to 9.5
Spot separation (mm) 2.2
Line separation (mm) 2.2
Bed energy (mJ) 0.65
Depth (mm) 300
Side-cut energy (mJ) 1.60 to 1.70
Side-cut angle (mJ) 30
Pocket Deactivated
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lens in the pocket based on the marked area on the cornea.
After insertion, the surgeon verified that the intracorneal
inlay was properly centered in the pocket. If there was a
need for recentration, the inlay was moved in the pocket by
massaging the surface of the cornea with a fine blunt spatula
or cannula or by manipulating the inlay in the pocket with a
small blunt cannula. A bandage contact lens was applied
before the speculum was removed; the bandage contact lens
was removed the day after surgery. Operated eyes were not
patched. All patientswere instructed to instill topical levoflox-
acin in combination with topical tobramycin–dexamethasone
4 times daily for 1 week, after which they were instructed to
taper by 1 drop per week over 4 weeks.Patient EvaluationAll patients had an extensive ocular examination (mani-
fest refraction, visual acuity testing, tonometry, pachymetry,
keratometry, slitlamp biomicroscopy) including IVCM
(Confoscan 4, Nidek Technologies Srl) andAS-OCT (Visante,
Carl Zeiss Meditec AG) evaluations. In vivo confocal micro-
scopy was performed by the same examiner (A. C.) in all
study eyes before surgery and 1, 6, and 12 months after sur-
gery. One drop of proparacaine 0.5% solution and artificial
tears were instilled immediately before each examination.
Patients were asked to look straight ahead, and an in vivo
confocal microscope equipped with a standard 40.0 D
water-immersion front lens automatically captured images
of the full thickness of the central cornea. Each examination
took approximately 3 minutes and recorded 350 images at
a distance of 1.5 mm between successive images on the z-
axis. Scanning was performed from the epithelium to the
endothelium, paying special attention to the stromal inter-
face and inlay edges. The interfacewas defined as the corneal
sublayer in the stromawith evident discontinuity of the stro-
mal keratocyte and extracellular matrix (ECM) architecture.
A postoperative ECD was obtained for each eye at every
follow-up examination. The center of the cornea was also
evaluated and studied at all examinations.
Anterior segment OCT examinations and images of the
cornea were taken by the same experienced examiner
(A.M.) 1, 6, and 12 months after surgery to assess the
morphology, characteristics, and pachymetry of the cornea
and pocket. Measurements were repeated 3 times per patient
to increase the accuracy of the recorded value. The AS-OCTJ CATARACT REFRACT SURGproduced multiple A-scans that formed 2-dimensional
images of the cornea using low-coherence interferometry.
All images were taken using the “high res corneal” scan
option to obtain accurate scans of the corneal structure; a
linear transversal scan with the same orientation of the
corneal pocket and its orthogonal scan was used in an unac-
commodated state and under the same light conditions
(50 lux). All patients were asked to look at the optical target
in the system. When the corneal reflex (ie, a vertical white
line along the center of the cornea) was visible, images
were captured. The captured linear scan was rotated 10 de-
grees clockwise and 10 degrees counterclockwise to identify
the image with the best resolution.
After images were obtained, several corneal features were
analyzed. The first feature was the angle of the side cut
between the edges of the epithelium and the stromal pocket.
The second was the seal of the pocket and the resulting reg-
ularity of its profile (ie, pocket regularity). The third feature
was the difference between the planned and achieved pocket
depth, calculated as the distance between the proper inter-
face and the epithelial layer (pocket accuracy); each docu-
mented interface depth was the mean of 3 measurements.
The final feature analyzed was the interface pocket reflectiv-
ity, calculated as the number of light reflectance units visible
near the intracorneal inlay. The pachymetry-scan pattern
was used to map the cornea; the mean pachymetry of the
central 2.0 mm area was recorded as the CCT for OCT
measurements.RESULTSBaseline CharacteristicsThe intracorneal inlay was inserted in the nondom-
inant eye of 52 naturally emmetropic presbyopic
patients. The mean age of the 36 men and 16 women
was 56.1 years (range 46 to 63 years). The mean
follow-up after inlay insertion was 7.6 months (range
4 to 12 months). Thirty-six patients (69.2%) presented
for the 12-month follow-up visit.
Postoperative slitlamp examinations showed clear
corneas without evidence of thinning, scarring, or
vascularization and well-centered inlays at all time-
points in all eyes (Figure 1). All remaining ocular
examinations were normal. Three inlays were
explanted before the 6-month visit due to patient-
reported significant discomfort caused by a reduction
in distance vision and the presence of significant halos
and glare; 3 additional explantations occurred before
the 12-month visit. The mean preoperative CDVA of
patients having explantation was 0.06 logMAR
with a mean refractive SE of 0.16 D; the mean postex-
plantation CDVA was 0.00 logMAR with a mean
refractive SE of 0.23.In Vivo Confocal MicroscopyThe epithelium, including the superficial epithelial
cells and intermediate and basal cell layers, showed
well-described normal structures of healthy corneas
in all eyes at all follow-up examinations. The basal- VOL 40, APRIL 2014
Figure 1. The intracorneal inlay in the eye of a patient 12 months
postoperatively.
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epithelial layer images showed hyperreflective dots
in several eyes 1 month postoperatively; however,
this phenomenon was not present at the 6- or
12-month examination (Figure 2).
Bowman membrane appeared as a nonreflective
structure, and the beaded nerve fibers of the subepi-
thelial nerve plexus were the only distinguishable ele-
ments. At 1 month, the subbasal nerve plexus images
showed a small reduction in the number of nerves
with increased tortuosity and reflectivity, which
decreased by 6 months postoperatively. SomeJ CATARACT REFRACT SURGbeadlike formations, defined as highly reflective
bulbous portions of the subbasal nerve, were also
observed. By 12 months postoperatively, all patients
had regained the nerve morphologic features imaged
preoperatively (Figure 3).
The anterior stroma under the basal membrane was
normal in all eyes, and only slight reflections from the
keratocyte nuclei were seen against a darker back-
ground. Moreover, in the early postoperative period,
these cells were surrounded by hyporeflective irreg-
ular areas of mild edema (Figure 4, A, B). At 12
months, the anterior stroma appeared normal with
few activated keratocytes (Figure 4, C, D).
At 1 month, many small, bright, round cells of
various sizes and a few highly reflective dendritic-
shaped cells with short branching were visible just
near the treated stroma in all eyes (Figure 5, A).
Many bright oval or round microdots were clearly
visible in the anterior and intermediate stroma, and
increased deposition of what appeared to be abnormal
ECM was observed in the anterior stroma near the in-
tracorneal inlay (Figure 5, B). Diffuse deposits of
dystrophic material interspersed between the kerato-
cyte nuclei were found in the intermediate stroma.
The keratocytes of the mild stroma were more acti-
vated, and a large zone of what appeared to be
apoptotic keratocytes was found on the anterior sur-
face of the corneal inlay (Figure 5, C). Hyperreflective
areas and an irregular amorphous structure or pattern
were seen on the anterior surface of the intracorneal
inlay near the interface of the pocket in all eyes.Figure 2. In vivo confocal microscopy. The
epithelium appears normal with some hy-
perreflective dots in the basal epithelial
layer. The dots disappeared by 6 months
postoperatively (scaleZ 100 mm).
- VOL 40, APRIL 2014
Figure 3. In vivo confocal microscopy
shows a small reduction in the number of
nerves with increased tortuosity and re-
flectivity and beadlike formations at 1
month in the subepithelial nerve plexus;
regular nervous morphologic features
were observed 12 months postoperatively
(scaleZ 100 mm).
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lated stromal edema were also surrounded by these
hyperreflective structures (Figure 5, D). At 6 months,
24 of 47 eyes had hyperreflective cells, indicating
possible fibroblastic activity and small, insignificant
isolated haze in the intermediate stroma (Figure 6, A,
B). After 12 months, a few hyperreflective keratocyteJ CATARACT REFRACT SURGnuclei were visible above a slight hyperreflective back-
ground, indicating the anterior surface of the inlay
(Figure 6, C, D).
The edge of the corneal inlay with its central hole
was clearly seen (Figure 7). The posterior corneal
stroma was normal in all eyes. Hyporeflective perpen-
dicular lines of microstriae were observed in a fewFigure 4. In vivo confocal microscopy. A
and B: Keratocytes surrounded by hypore-
flective irregular areas of mild edemawere
seen in the anterior stroma 1 month post-
operatively. C and D: The anterior stroma
appeared normal with few activated kera-
tocytes at 12 months (scaleZ 100 mm).
- VOL 40, APRIL 2014
Figure 5. In vivo confocal microscopy. A:
Small, bright, round and highly reflective
dendritic-shaped cells with short branch-
ing. B: Bright oval or round microdots
and deposition of abnormal ECM are
visible in the area near the treated stroma.
C: Activated keratocytes with dystrophic
material at the level of the mid stroma
were seen. D: Hyperreflective areas and
irregular amorphous structure sur-
rounded by isolated stromal edema on
the anterior surface of the corneal inlay
(scaleZ 100 mm).
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they decreased by the 12-month postoperative visit
(Figure 8, A, B). The endothelial cells on the endothe-
lium directly beneath the intracorneal inlay appeared
to be of regular size and structure (polymorphism
and polymegathism) at all follow-up visits (Figure 8,
C, D). The mean ECD was 2401 cells/mm2 G 218
(SD) preoperatively, 2378 G 282 cells/mm2 at 1J CATARACT REFRACT SURGmonth, and 2439G 297 cells/mm2 at 12 months; there
were no statistically or clinically significant changes in
ECD during the postoperative follow-up.Anterior Segment Optical Coherence TomographyThe AS-OCT device provided images of the entire
cornea, pocket, and intracorneal inlay section of theFigure 6. In vivo confocal microscopy. A
and B: At 6 months, fibroblastic activity
and small isolated haze were seen in the
intermediate stroma. C and D: After
12 months, few hyperreflective keratocyte
nuclei were visualized through the lens
above a slight hyperreflective background
(scaleZ 100 mm).
- VOL 40, APRIL 2014
Figure 7. In vivo confocal microscopy (reconstruction of image)
shows the edge of the intracorneal inlay with its central hole (scale
Z 100 mm).
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incisionqualitywas excellent inall eyes.Themeanvalue
of the angles, trigonometrically calculated using OCT
measurement parameters, was 30.7 G 0.5 degrees.
There was no evidence of epithelial gape or misalign-
ment (Figure 9). Themorphology of the flap and pocket
showed a regular planar shape in all eyes (Figure 10,A).
The pocket was visible as a hyporeflective meniscus in
the center of the cornea with gradually increased linear
reflectivity toward the periphery. The mean combined
value of the central pocket depth and the intracorneal
inlay interface was 292.14G 10.75 mm at 1 month andJ CATARACT REFRACT SURG290.23 G 9.51 mm at 12 months (Figure 10, B).
The mean difference between the measured pocket
depth and the planned pocket depth was 7.86 mm and
9.77 mm at 1 month and 12 months, respectively. The
mean interface depth remained stable without signifi-
cant variations during the entire follow-up.
At 1 month, the AS-OCT examination showed slight
diffuse edema in all eyes. There were some hyperre-
flective areas beneath the intracorneal inlay, represent-
ing the femtosecond laser–treated area (Figure 11, A).
Microfolds were observed in some eyes at the level
of the interface (Figure 11, B). After 12 months, a regu-
lar anterior segment profile was seenwith complete re-
covery of the central and peripheral stroma and a
reduction in hyperreflective areas (Figure 11, C).
Interface pocket reflectivity, defined as the number
of high reflectivity areas identified, was calculated
(Figure 11, D). Twenty-one (40.3%) of 52 eyes at 1
month and 19 (52.8%) of 36 eyes at 12 months showed
more than 3 visible light-reflectance units near the in-
tracorneal inlay. The significance of these reflective
areas was unknown, and the number of reflectance
units diminished during the postoperative follow-up.
The mean CCT was 568G 37 mm preoperatively, 559
G 41 mm at 1 month, 558 G 39 mm at 6 months, and
551G 47 mm at 12 months.In Vivo Confocal Microscopy and Anterior Segment
Optical Coherence Tomography After Inlay RemovalThree of 6 patients who had inlay explantation were
followed for an additional 6 months after explantationFigure 8. In vivo confocal microscopy. A:
Hyporeflective perpendicular lines visual-
ized as microstriae in the posterior corneal
stroma B: Reduction was seen 12 months
postoperatively. C andD: Endothelial cells
are regular in size and structure (scale Z
100 mm).
- VOL 40, APRIL 2014
Figure 9.Anterior segmentOCT shows the
side-cut angle of the pocket. Note the
absence of epithelial gape and misalign-
ment (scaleZ 500 mm).
552 IN VIVO CONFOCAL MICROSCOPY AND AS-OCT OF BIFOCAL REFRACTIVE CORNEAL INLAY IMPLANTATIONandwere examinedwith IVCMandAS-OCT 6months
after inlay removal. Ocular biomicroscopy showed
clear corneas without pocket alterations or signs of
irregularity in all 3 eyes. Under IVCM, slight fibrosis
was visible in the intermediate stromal section near
the pocket in which the inlay had been implanted
(Figure 12, A); a few highly reflective microdots were
detectable (Figure 12, B). The endothelium appeared
healthy without signs of polymorphism in all 3 eyes.
Anterior segment OCT cross-sectional images of the
cornea showed uniform corneas in all eyes without a
change in shape or epithelial surface irregularities.Figure 10. Anterior segment OCT. A: Regular planar shape of the
flap is seen. The pocket is of a hyporeflective meniscus shape with
gradual increased reflectivity toward the periphery. B: Evaluation
of the central pocket thickness and the inlay interface (scale Z
500 mm).
J CATARACT REFRACT SURGThe stromal pocket was not easily detectable, even
when it was possible to visualize it in the early postop-
erative period. In some sections, a discontinuous
hyperreflective line (Figure 12,C) was visible 6months
after inlay explantation (Figure 12, D).
DISCUSSION
The concept of an intracorneal implant for the correc-
tion of presbyopia has a long history. In 1964, Barra-
quer12 used flint glass; however, anterior stromal
necrosis occurred followed by extrusion of the
implant. Implantation of several corneal inlays of
different materials using different surgical techniques,
including depth of implantation, have been described
in the literature; however, many complications were
associated with implantation of earlier designs. Com-
plications included corneal stroma opacity, haze,
deposits, infiltration, corneal necrosis, and inadequate
nutrition flow between the anterior and posterior
layers of the cornea.13,14
Recently, the interest in intracorneal implants has
resurfaced, driven by advances in biosynthetic mate-
rials and microkeratome and femtosecond laser tech-
nology. At present, the Flexivue Microlens is among
the newest generation of intracorneal inlays. This inlay
is designed to treat presbyopia by its unilateral
implantation in the nondominant eye.
To our knowledge, this series is the first to report the
outcomes of IVCM and AS-OCT examinations of
corneal features in eyes with a Flexivue Microlens. We
believe this is because the procedure is relatively new- VOL 40, APRIL 2014
Figure 11.Anterior segment OCT.A: Area of eye that had femtosecond laser pocket creation. Hyperreflective areas are seen beneath the inlay. B:
Microfolds on the interface (white arrows). C: After 12 months, reduction of hyperreflective areas was observed. D: High reflectivity areas in the
interface (red arrows) (scaleZ 500 mm).
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not been fully characterized. The outcomes in our series
showed that the corneal tissue in eyes tolerated the pres-
ence of the inlay without difficulty; however, some is-
sues were encountered that require consideration.
There are always concerns regarding placement of a
synthetic material in the cornea. The ideal synthetic
material should be permeable enough to allow
adequate nutrient flow through the cornea because
virtually all corneal nutrients come from the aqueous
humor.15 The material used in the inlay design should
also maintain original optical properties after implan-
tation. If an intracorneal implant interrupts the flow of
glucose and other nutrients to the corneal tissue
located anteriorly to it, progressivemelting of the ante-
rior cornea and loss of transparency can result. In a
study of corneal tissue integrity, Sweeney et al.16 deter-
mined that a pore size of 100 nm (diameter and totalJ CATARACT REFRACT SURGarea) in the membrane material implanted in feline
corneas was better than a pore size of 50 nm or less
in providing long-term nutrient flow to the cornea.
Dohlman et al.17 recognized the importance of water
and nutrient movement across the cornea from the
aqueous humor. However, glucose transport
decreased significantly as the thickness of the implant
increased; to obtain the desired refractive effect, they
determined the ideal implant diameter should be
between 270 mm and 340 mm.
Based on the CCT outcomes in our series (ie, no
change in CCT), the small hole in the center of the Flex-
ivue Microlens provided sufficient nutritional flow of
glucose and other metabolic substances. In addition,
lipid or other deposits, such as those seen with other
intracorneal implants, including hydrogel intracorneal
inlays and intracorneal ring segments,18,19 were not
observed over the 12-month follow-up.Figure 12. In vivo confocal micro-
scopy. A: Eye of patient after inlay
removal with slight fibrosis in the
intermediate stromal sections near
the pocket. B: Small high reflective
microdots also present (scale for A
and B Z 100 mm). C: On AS-OCT
examination, the stromal pocket is
detectable in the early period as a
discontinuous hyperreflective line
(white arrow). D: Line has disap-
peared by 12 months (scale for C
and DZ 500 mm).
- VOL 40, APRIL 2014
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the visual outcomes and structural corneal alterations
using IVCM after the implantation of the Invue refrac-
tive intrastromal inlay (Biovision AG) in a corneal
pocket created using a mechanical microkeratome.
Normal epithelial cells, subepithelial nerve plexus,
keratocyte scattering, and endothelial morphology
were observed at depths below and above the inlay
12 months postoperatively. In our series, IVCM was
used to assess the changes in corneal morphologic
features after Flexivue Microlens insertion in all
patients and after removal in 6 patients. Our results
showed an almost inert response of the corneal tissue
to the presence of the inlay. The epithelial layers of
the cornea maintained their integrity and were mini-
mally altered by the procedure. In some eyes, the pres-
ence of hyperreflective dots could suggest an increase
in epithelial activity after the surgical procedure.
The results of the examination of the subepithelial
nerve plexus should be considered. During LASIK,
the superficial stromal nerves are cut in the flap
margin and the nerves in the stromal bed under the
flap are subsequently exposed to excimer laser photo-
ablation.21 Flap cutting and laser ablation contribute to
innervation damage, which develops after LASIK.
Post-LASIK corneas, which have undergone signifi-
cant sensory denervation, tend to present with thicker
epithelium; IVCM images showed that the subbasal
nerve density decreased 90% 1 month after LASIK
and that the density began to recover by 3 to 6
months.22 One important finding in this series is that
the pocket approach may minimize the impact on
corneal nerves. In fact, IVCM examinations showed
no signs of alteration of the subbasal nerve plexus
in the eyes. The beadlike formations seen under
IVCM were characteristic of metabolically active
transmitter-containing nerve fibers. The higher num-
ber of beadlike formations and the higher tortuosity
were indicative of high metabolic activity, possibly
directed toward repairing corneal alterations.23
In the early postoperative period, there was some
evidence of degenerative cells and cell debris near
the inlay in several cases. There are several possible
causes for these corneal changes. First, creation of the
corneal pocket creates a wound that never fully heals
and resolves as a small corneal microscopy modifica-
tion. Although this is insufficient in itself to interfere
with visual outcomes, as seen in post-LASIK surgery
cases, incising the cornea results in some direct phys-
ical damage to keratocytes. Second, the presence of
the inlay in corneal tissue may set up a very subtle,
yet continuous response in the stromal keratocytes
that persists for as long as the inlay is present. Third,
the presence of products of degenerative cell pro-
cesses, such as lipids around the inlay, combinedJ CATARACT REFRACT SURGwith the slow accumulation of other surgically related
byproducts near the inlay may also be involved. In
fact, in the early postoperative period, many hyperre-
flective microdots were visible as diffuse deposits of
dystrophic material interspersed between activated
keratocyte nuclei, with a progressive accumulation of
abnormal ECM in the stroma near the inlay. These
particles may be related to cell degradation products
of the ablated corneal tissue, dust or air particles
from the operating room, sterile swab remnants, secre-
tory material from the meibomian gland, tear-film
debris, a different type of collagen produced in
response to the incision, or remains of apoptotic kera-
tocytes.24 In a recent study of small particles detected
via in vivo confocal microscopy,25 the authors corre-
lated ex vivo confocal microscopy with histology
and ultrastructural evaluation and suggested that
these particles may be small, clear intracytoplasmic
vacuoles within keratocytes.
In our series, the inlay surfaces and borders were
easily detected on IVCM as hyperreflective areas. In
the post-incision tissue reaction immediately after sur-
gery, limited areas of stromal edema were observed as
dark areas at the pocket interface. Under IVCM, the
eyes had activated hyperreflective keratocytes in
places that were in direct contact with the inlay on
anterior and posterior surfaces. Extracellular matrix
and cellular debris that resulted from the degeneration
of keratocytes were also evident around the inlay.
Activated keratocytes, presenting as cells with
increased nuclear reflectivity in the stroma, were
seen when the cellular metabolic activity was
increased and were present in the vicinity of the inter-
face at the 1-month follow-up; this activity decreased
with time. No inflammatory cells or neovasculariza-
tion were observed in the vicinity of the inlay after
the 12-month follow-up. Keratocytes posterior to the
post-interface activation area appeared quiet at all
follow-up examinations. The deep corneal stroma in
eyes was normal and quiescent; however, early in
the postoperative follow-up, perpendicular hypore-
flective lines (microstriae) were detected. These micro-
striae might be the result of interface stretching during
the procedures and of transient edema that tempo-
rarily compressed the posterior corneal surface, which
is more susceptible to deformation. The mean ECD in
the surgical eye remained stable.
Identification of the correct lens material and design
and determination of appropriate placement within
the cornea have presented a challenge to intracorneal
inlay manufacturers. Other intracorneal inlay designs
have been reported to cause corneal necrosis, epithelial
opacification, and problems related to inadequate
corneal nutrition.26 Deep placement of the inlay in
the cornea might be advantageous. In our series, the- VOL 40, APRIL 2014
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results in a study that determined that deeper stroma
has less impact on oxygen and nutrient diffusion in
the corneal stroma.27 Use of IVCM showed the
biocompatibility of the Flexivue Microlens and indi-
cated that it did not alter the cellularity and meta-
bolism of corneal layers in this study. Similarly,
AS-OCT allowed us to evaluate the impact of deep
placement of the inlay on the corneal architecture.
This deep placement creates a thicker “flap” (in this
case a corneal pocket) that might minimize the risk
for complications and prevent changes in the shape
of the anterior cornea.3 Another study confirmed
that a thicker flap minimizes postoperative flap com-
plications28; shallow placement, as seen with Permavi-
sion (Anamed) intracorneal implantation, induced
epithelial thinning, keratocyte loss, and keratocyte
activation when flaps between 110 mm and 180 mm
were used.29 In our study, corneal pockets were be-
tween 280 mm and 300 mm, which is thicker than the
170 mm used in previous studies; no melting, stromal
thinning, or other flap-related complications were re-
ported. The change in the mean CCT from preopera-
tively to postoperatively was not significant,
providing further evidence that the inlay did not alter
the overall structure of the cornea.
Another study30 found that AS-OCT monitoring
was useful in evaluating the profile of side cuts and
the precise depth of corneal pockets immediately after
surgery and in the late postoperative period. In our se-
ries, AS-OCT showed that the angle of side cuts and
overall incision quality were excellent; the angles of
all side cuts were in the range required to obtain secure
corneal incisions, providing enhanced wound stability
and resulting in regularity of the corneal stromal
pockets. The location of the pocket interface and inlay
were visible in the eyes due to the reflectivity of inter-
face particles and dark lines in the intermediate
stroma. The particles were almost always present but
varied in the number and intensity of reflectance. In
some cases, the reflection from the interface surfaces
was very bright. The source of these reflections was
likely cells or extracellular deposits coating the surface
of the inlay. The AS-OCT evaluation showed no corre-
lation between pocket-interface reflectivity and parti-
cle density.
In this case series, the mean difference between
themeasured pocket thickness and the planned pocket
thickness was very small 1 month and 12 months
after surgery, and the mean interface depth remained
stable during the postoperative follow-up. Using
the 150 kHz femtosecond laser in conjunction with
the applanation cone mask created consistent and
predictable corneal pockets. In another study,31
use of the 150 kHz femtosecond laser rather than aJ CATARACT REFRACT SURGmicrokeratome to create the corneal pocket provided
better predictability in pocket surface dimensions (ie,
smooth stromal bed creation), a precise target depth
(between 280 mm and 300 mm), a lower incidence of
LASIK-induced dry eye, improved contrast sensi-
tivity, improved visual recovery (as seen in enhanced
UDVA results relative to microkeratomes), and
improved patient satisfaction. As reported by Zhang
et al.,32 consistency in flap or pocket architecture
contributed to better clinical results; as the precision
of the flap or pocket increased, the stability of the
cornea increased, which resulted in decreased epithe-
lial injury and so forth.
Improved pocket accuracy and regularity using a
femtosecond laser of 150 kHz or greater in conjunction
with an applanation cone mask are key factors to
improve the safety and predictability of this proce-
dure. In our study, the laser parameters for flap
creation were modified to obtain smooth stromal
beds through use of a mask for pocket creation. This
was a key factor that led to a decrease in stromal bed
irregularities created by the laser.33 In our study,
AS-OCT examinations showed small microfolds of
the pocket in most eyes; however, the clinical signifi-
cance of this slight microfolding appeared negligible
and may have been a result of stretching of the pocket
during surgery or of the inlay's shape and thickness.
Based on the design of the Flexivue Microlens, the
thickness of the inlay did not alter the interface
morphologic features in our patients 1 month after
surgery, which is similar towhatwe see in our patients
who have had traditional LASIK.
Additive technologies, such as that provided by
the Flexivue Microlens, offer several advantages
over currently used refractive surgical techniques.
The greatest advantage is that the inlay can be
removed; thus, the procedure has the potential of
being adjustable. Although there were 6 explanta-
tions (3 before the 6-month postoperative follow-up;
3 before the 12-month follow-up) during our study,
none was related to the biocompatibility of the inlay
material or to metabolic compromise of the anterior
corneal tissue. Our IVCM and AS-OCT results show
that the procedure is reversible and that after inlay
removal, there was no significant alteration in the
corneal tissue.
In conclusion, considering that the inlay does not
require removal of corneal tissue or intraocular
surgery and that the procedure is reversible (ie, the
inlay can be explanted), the outcomes in our case
series show that the Flexivue Microlens was well
tolerated for the duration of the 12-month follow-
up. The IVCM analysis showed that the inlay was
biocompatible with corneal tissues, eliciting a low-
level wound-healing response that was confined to- VOL 40, APRIL 2014
556 IN VIVO CONFOCAL MICROSCOPY AND AS-OCT OF BIFOCAL REFRACTIVE CORNEAL INLAY IMPLANTATIONthe stromal tissue in its immediate vicinity. The AS-
OCT evaluation confirmed no alteration in the
corneal structure and shape and that the surgical pro-
cedure was repeatable.WHAT WAS KNOWN
 Recent advances in femtosecond lasers and material
technologies are contributing factors to a renewed inter-
est in intracorneal inlay options to treat presbyopia.WHAT THIS PAPER ADDS
 The intracorneal inlay showed excellent biocompatibility
with corneal tissue.
 After inlay insertion in the deep stroma, IVCM was useful
in evaluating postoperative corneal wound healing and
AS-OCT was useful in evaluating the corneal structural
features and repeatability of the surgical procedure.
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